Neuropace Inc
NASDAQ:NPCE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Neuropace Inc
NASDAQ:NPCE
|
US |
|
Sofina SA
XBRU:SOF
|
BE |
|
Calfrac Well Services Ltd
TSX:CFW
|
CA |
|
C
|
Chime Financial Inc
NASDAQ:CHYM
|
US |
|
S
|
Stockmann Oyj Abp
F:SOMB
|
FI |
|
Canopy Growth Corp
TSX:WEED
|
CA |
|
C
|
Clover Health Investments Corp
F:7QD
|
US |
|
C
|
CapitaLand Integrated Commercial Trust
F:M3T
|
SG |
|
C
|
Christian Dior SE
XMUN:DIO
|
FR |
|
A
|
AMN Healthcare Services Inc
F:HCQ
|
US |
|
Owens & Minor Inc
NYSE:OMI
|
US |
|
I
|
Indocement Tunggal Prakarsa Tbk PT
SWB:ITP
|
ID |
|
Assetco PLC
LSE:ASTO
|
UK |
|
Escalade Inc
NASDAQ:ESCA
|
US |
|
S
|
StubHub Holdings Inc
NYSE:STUB
|
US |
|
Advanced Petrochemical Co SJSC
SAU:2330
|
SA |
|
Laureate Education Inc
NASDAQ:LAUR
|
US |
|
Grupo Rotoplas SAB de CV
OTC:GRPRF
|
MX |
|
C
|
CBAK Energy Technology Inc
F:B6JA
|
CN |
|
Sprout Social Inc
NASDAQ:SPT
|
US |
|
N
|
Nedbank Group Ltd
SWB:NCO
|
ZA |
|
Valeo Pharma Inc
TSX:VPH
|
CA |
|
S
|
SoftBank Group Corp
OTC:SFTBF
|
JP |
|
S
|
Starflex PCL
SET:SFLEX
|
TH |
Wall St Price Targets
NPCE Price Targets Summary
Neuropace Inc
According to Wall Street analysts, the average 1-year price target for
NPCE is 20.25 USD with a low forecast of 18.18 USD and a high forecast of 23.1 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NPCE's stock price target?
Price Target
20.25
USD
According to Wall Street analysts, the average 1-year price target for
NPCE is 20.25 USD with a low forecast of 18.18 USD and a high forecast of 23.1 USD.
What is the Revenue forecast for Neuropace Inc?
Projected CAGR
15%
Over the last 5 years, the compound annual growth rate for Revenue has been 19%. The projected CAGR for the next 5 years is 15%.